THYROID CANCERS

Latest News

Selpercatinib Wins FDA Accelerated Approval for RET-Altered Tumors in Pediatric Patients
Selpercatinib Wins FDA Accelerated Approval for RET-Altered Tumors in Pediatric Patients

May 29th 2024

The approval of selpercatinib marks the first targeted therapy for pediatric patients with RET gene alterations in solid and thyroid tumors.

SELECT Trial Establishes Lenvatinib’s Role in RAI-Refractory DTC
SELECT Trial Establishes Lenvatinib’s Role in RAI-Refractory DTC

May 2nd 2024

Establishing Risk Factor Assessment in Papillary Thyroid Microcarcinoma
Establishing Risk Factor Assessment in Papillary Thyroid Microcarcinoma

April 18th 2024

Understanding Mutations and Targeted Treatments in Thyroid Cancer
Understanding Mutations and Targeted Treatments in Thyroid Cancer

April 17th 2024

Optimizing Thyroid Cancer Care: New Tools and Emerging Options
Optimizing Thyroid Cancer Care: New Tools and Emerging Options

March 12th 2024

Latest CME Events & Activities

Oncology Consultations®: Next Generation SERDs—Key Data and Practical Takeaways for the Community Physician

View More

Medical Crossfire®: Leveraging Multidisciplinary Teams in Early–Stage Breast Cancer When the Goal is Cure

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

23rd Annual International Congress on the Future of Breast Cancer® East

July 19-20, 2024

Register Now!

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed

View More

Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease

View More

Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

42nd Annual CFS®: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

More News